Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cancer Support Community San Francisco Bay Area Launches Initiative to Provide Digital Cancer Care to Underserved Communities

    Apr 25, 2023, 11:38 AM by
    Equiva Healthcare and Cancer Support Community (CSC) San Francisco Bay is announcing the activation of a new initiative to improve access to cancer support and education for those residing in under-connected Bay Area communities. The CSC Bay Area is the second CSC location to launch this program aimed at relieving the inequities and disproportional burden that cancer patients for certain population experience. Digital oncology support resources will be distributed using Equiva's Affordable Connectivity Program(ACP)-centric solution. CSC Bay Area will work with eligible households to enroll them in FCC’s ACP (which provides discounted broadband service) and distribute tablets to patients so they can access important cancer support services and resources.
    Full story
  • Follow the Money: Multi-omic Drug Discovery, Antibody Manufacturing, Biopolar Focus, More

    Apr 25, 2023, 01:00 AM by User Not Found
    Bio-IT World | Big money for small-batch antibodies, investment in understanding bipolar disorder, Mercy BioAnalytics nets Series A for detecting cancer biomarkers on the surface of tumor-derived extracellular vesicles; and more.
    Full story
  • Embracing Automation to Integrate Medical Information and Safety Operations

    Apr 21, 2023, 01:00 AM by User Not Found
    Bio-IT World | Businesses depend on data to inform strategy and measure success across all industries. To benefit from automated workflows, life sciences organizations must integrate disparate systems. End-to-end, open architecture solutions facilitate communication between multiple platforms with minimal friction or tedious, time-consuming middle steps.
    Full story
  • Bio-IT World Names 2023 Innovative Practices Winners

    Apr 19, 2023, 01:00 AM by User Not Found
    Bio-IT World| Bio-IT World today announced the 2023 Innovative Practices Awards winners. Six projects were honored. Companies involved in the winning entries included AbbVie, Bayer G4A; Carenostics; City of Hope; Generate Biomedicines; Hackensack Meridian Health; Higher Steaks; Regeneron Pharmaceuticals; SciBite; and Synthace.
    Full story
  • Deep Proteome Sequencing Answers Longstanding Biology Question

    Apr 18, 2023, 14:01 PM by User Not Found
    Bio-IT World | Debate about whether RNA splicing events code for different proteins may finally be over, thanks to international research efforts and a new sequencing method that enumerates the massive number of human protein alterations in standard proteomics experiments.
    Full story
  • NVIDIA and Mitsui Launch Japan’s First Generative AI Supercomputer to Accelerate Drug Discovery

    Apr 14, 2023, 01:00 AM by User Not Found
    Bio-IT World | In collaboration with NVIDIA, Mitsui, Japan, recently launched Tokyo-1, a supercomputer designed to boost Japan’s $100B pharmaceutical industry. The project features 16 NVIDIA DGX H100 AI systems—a part of NVIDIA’s NGX enterprise AI platform—to simulate high-resolution molecular dynamics and generate AI models for accelerated drug discovery.
    Full story
  • BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

    Apr 13, 2023, 10:30 AM by
    BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.
    Full story
  • Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

    Apr 13, 2023, 10:29 AM by
    Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency
    Full story
  • Blue Spark Technologies to Present New Standard of Care for Temperature Monitoring at HIMSS 2023

    Apr 13, 2023, 10:26 AM by
    Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the HIMSS Global Health Conference & Exhibition at McCormick Place Convention Center in Chicago April 17-21.
    Full story
  • CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death

    Apr 13, 2023, 10:02 AM by
    CD BioSciences has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death.
    Full story
  • STEMart Launches Bioburden and Sterility Testing for Medical Devices

    Apr 13, 2023, 10:01 AM by
    STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.
    Full story
  • Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection

    Apr 13, 2023, 10:00 AM by
    Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.
    Full story
  • Main Ingredients of Cosmetics: Salicylic acid, AHA, Retinol, Avobenzone, Titanium dioxide

    Apr 13, 2023, 09:58 AM by
    Full story
  • Introducing DroidGPT: AI that helps you select better open source software

    Apr 13, 2023, 09:55 AM by
    Endor Labs, the startup helping development and security teams maximize the use of open source software (OSS), today launched in private beta Endor Labs DroidGPT – an AI that can help developers select better open source software.
    Full story
  • Protein-Metabolite Interactome Is Vast Untapped Frontier For Drug Discovery

    Apr 13, 2023, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the University of Utah have created a systematic approach to reveal the endogenous protein-metabolite interactome at high-throughput speed. The platform quickly identifies metabolites that putatively interact with target proteins.
    Full story
  • AI-Based Retinal Aging Clock Gauges Effectiveness Of Anti-Aging Interventions

    Apr 11, 2023, 01:01 AM by User Not Found
    Bio-IT World | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.
    Full story
  • BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global PartnersBOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners

    Apr 7, 2023, 11:46 AM by
    In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.
    Full story
  • CD ComputaBio Boosts Small Molecule Drug Development with Protein-Small Molecule Docking Service

    Apr 7, 2023, 11:44 AM by
    Full story
  • High-Performance OLED and PLED Materials

    Apr 7, 2023, 11:42 AM by
    Full story
  • Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials

    Apr 7, 2023, 11:41 AM by
    Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.
    Full story
  • «
  • 81
  • 82
  • 83
  • 84
  • 85 (current)
  • 86
  • 87
  • 88
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy